Document is current

Article History

Received: 27 July 2022

Accepted: 18 October 2022

First Online: 10 January 2023

Conflict of interest

: R. Akiba, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju); M. Takahashi, Grants or contracts (DSP, NICHIREI BIOSCIENCES, Nikon), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Intellim, Alcon, Santen, Novartis, Bayer, Roche), Payment for expert testimony (Novartis, Biogen, Astellas), Participation on a Data Safety Monitoring Board or Advisory Board (Sparing Vision, Sysmex, Suimin), Stock or stock options (Vision Care), Other financial or non-financial interests (Vision Care, VC Cell Therapy, VC Gene Therapy); T. Baba, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Bayer, Santen, Alcon, Novartis, Senju, Chugai, Kowa); M. Mandai, Grants or contracts (Vision Care, VC Cell Therapy, VC Gene Therapy, TOMEY, DSP, Sysmex, PPD-SNBL), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Bayer, Otsuka, Novartis).